In the news


Explore the latest Leaps investments, news on our companies, thought leadership, and press resources.

In the news

Leaps events


Spotlight on Juergen Eckhardt


Juergen Eckhardt is EVP and Head of Leaps by Bayer, the impact investment arm, and Head of Business Development, & Licensing (BD&L) for the Pharmaceuticals division. He is a medical doctor and venture investor in healthcare, biotech, and agriculture with more than 20 years of experience. He is a strong believer that scientific breakthroughs can help us overcome some of humanity’s biggest challenges, including to cure and prevent chronic disease and to feed an ever-growing world population in a sustainable way – in short: science for a better life. He holds an MD from the University of Basel, Switzerland, and an MBA from INSEAD in Fontainebleau, France.

Read More

Reports


Explore the latest reports and publications developed by Leaps by Bayer and our collaborators.

  • Thumbnail

    Learn about our custom impact measurement framework WALY and read about the impact magnitude of our portfolio.

    Download
  • LeapsbyBayer Ag Playbook 2024

    Learn how to bring AgTech products from concept to market.

    Download
  • Anualr review 2023

    Read about our 2023 milestones, portfolio company highlights, engagement activities, and more.

    Download
  • Taking 10 leaps for humanity

    See how our 10 Leaps framework could generate return for humanity.

    Download
  • Annual review 2022

    Read about our 2022 milestones, portfolio company highlights, engagement activities, and more.

    Download
  • Happiness Research Institute

    Read about the work with our partners at the Happiness Research Institute.

    Download

Press Kit


Leaps by Bayer is the impact investment arm of Bayer AG. We invest in teams pursuing fundamental breakthroughs in life science, targeting 10 huge challenges facing humanity.

Some call them impossible. We call them “Leaps”.

Media Contact


Kira Peikoff

Kira Peikoff is a former journalist who covered emerging biotechnologies for publications including The New York Times, Newsweek, and Popular Mechanics. She now leads communications for Leaps by Bayer.

https://leaps.bayer.com/Kira-Peikoff-profile-image-2.webp

Our return
to humanity

The Leaps team brings together a diverse group of individuals with expertise in biotech, healthcare, agriculture, investment, and communication.